[go: up one dir, main page]

AR036066A2 - Metodo para suministrar una droga a un ojo humano - Google Patents

Metodo para suministrar una droga a un ojo humano

Info

Publication number
AR036066A2
AR036066A2 ARP030101032A ARP030101032A AR036066A2 AR 036066 A2 AR036066 A2 AR 036066A2 AR P030101032 A ARP030101032 A AR P030101032A AR P030101032 A ARP030101032 A AR P030101032A AR 036066 A2 AR036066 A2 AR 036066A2
Authority
AR
Argentina
Prior art keywords
drug
human eye
sclera
eye
cannula
Prior art date
Application number
ARP030101032A
Other languages
English (en)
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of AR036066A2 publication Critical patent/AR036066A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Prostheses (AREA)
  • Medicinal Preparation (AREA)

Abstract

Un método para suministrar una droga a un ojo humano que comprende: insertar la cánula por debajo de la cápsula de Tenon y por encima de la esclera del ojo humano en un punto posterior al limbo del ojo, dicha cánula comprende una porción distal que tiene un radio de curvatura sustancialmente igual al radio de curvatura de la esclera de dicho ojo; e inyectar una droga a través de dicha cánula para formar un depot de droga sobre la superficie externa de dicha esclera, comprendiendo dicha droga un agente farmacéuticamente activo seleccionado del grupo formado por 4,9(11)-pregnadien-17alfa,21-diol-3,20-diona-21-acetato.
ARP030101032A 1999-10-21 2003-03-25 Metodo para suministrar una droga a un ojo humano AR036066A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16166099P 1999-10-21 1999-10-21

Publications (1)

Publication Number Publication Date
AR036066A2 true AR036066A2 (es) 2004-08-11

Family

ID=22582174

Family Applications (4)

Application Number Title Priority Date Filing Date
ARP000105478A AR026075A1 (es) 1999-10-21 2000-10-18 Una canula para distribucion sub-tenon de una droga
ARP030101036A AR039133A2 (es) 1999-10-21 2003-03-25 Canula
ARP030101031A AR036065A2 (es) 1999-10-21 2003-03-25 Un metodo para suministrar una droga en el ojo humano
ARP030101032A AR036066A2 (es) 1999-10-21 2003-03-25 Metodo para suministrar una droga a un ojo humano

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ARP000105478A AR026075A1 (es) 1999-10-21 2000-10-18 Una canula para distribucion sub-tenon de una droga
ARP030101036A AR039133A2 (es) 1999-10-21 2003-03-25 Canula
ARP030101031A AR036065A2 (es) 1999-10-21 2003-03-25 Un metodo para suministrar una droga en el ojo humano

Country Status (15)

Country Link
US (1) US6413245B1 (es)
EP (2) EP1221918B1 (es)
JP (1) JP2003511204A (es)
AR (4) AR026075A1 (es)
AT (1) ATE290837T1 (es)
AU (1) AU775149B2 (es)
BR (1) BR0014930B1 (es)
CA (1) CA2383572C (es)
DE (1) DE60018777T2 (es)
ES (1) ES2240180T3 (es)
HK (1) HK1049438B (es)
MX (1) MXPA02002376A (es)
PT (1) PT1221918E (es)
TW (1) TW467740B (es)
WO (1) WO2001028473A1 (es)

Families Citing this family (186)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936053B1 (en) * 1998-07-02 2005-08-30 Jeffrey N. Weiss Ocular implant needle
AU773367B2 (en) * 1999-04-26 2004-05-20 Gmp Vision Solutions, Inc. Shunt device and method for treating glaucoma
US7943162B2 (en) * 1999-10-21 2011-05-17 Alcon, Inc. Drug delivery device
US20020116020A1 (en) * 2000-02-02 2002-08-22 Kurenkov Vyacheslav Vladimirovich The cannula of kurenkov for carrying out of the operation of refractional correlating eximer laser intrastromal keratectomy (reik)
US7431710B2 (en) 2002-04-08 2008-10-07 Glaukos Corporation Ocular implants with anchors and methods thereof
ATE339170T1 (de) * 2001-07-23 2006-10-15 Alcon Inc Vorrichtung zur freisetzung eines ophthalmischen arzneimittels
WO2003009774A2 (en) 2001-07-23 2003-02-06 Alcon, Inc. Ophthalmic drug delivery device
JP4892800B2 (ja) * 2001-08-24 2012-03-07 株式会社ジェイ・エム・エス 薬液注入用針管、および該薬液注入用針管を装着した注射器
US7153316B1 (en) * 2001-11-09 2006-12-26 Mcdonald Marguerite B Surgical instruments and method for corneal reformation
US6802829B2 (en) * 2001-11-16 2004-10-12 Infinite Vision, Llc Spray device
WO2003068253A1 (en) * 2002-02-14 2003-08-21 Merck Patent Gmbh Methods and compositions for the treatment of eye diseases
JP2004041492A (ja) * 2002-07-12 2004-02-12 Scitec Kk 医療用針
DE10238310A1 (de) * 2002-08-21 2004-03-04 Erich Jaeger Gmbh Elektrodenanordnung
AU2003273339B2 (en) * 2002-09-17 2008-08-14 Iscience Interventional Corporation Apparatus and method for surgical bypass of aqueous humor
CA2689424A1 (en) * 2002-09-29 2004-04-08 Surmodics, Inc. Methods for treatment and/or prevention of retinal disease
US7141048B1 (en) * 2002-10-17 2006-11-28 Alcon, Inc. Vitreoretinal instrument
US7285107B1 (en) 2002-10-17 2007-10-23 Alcon, Inc. Vitreoretinal instrument
MXPA05008561A (es) * 2003-02-20 2005-11-04 Alcon Inc Uso de esteroides para tratar personas que sufren de trastornos oculares.
US20040167109A1 (en) * 2003-02-20 2004-08-26 Bingaman David P Formulations of glucocorticoids to treat pathologic ocular angiogenesis
US20040199130A1 (en) * 2003-04-03 2004-10-07 Chornenky Victor I. Apparatus and method for treatment of macular degeneration
RU2006101150A (ru) * 2003-06-13 2006-06-10 Алькон, Инк. (Ch) Композиции нестероидных противовоспалительных средств для лечения патологического ангиогенеза глаз
EP1635842A4 (en) * 2003-06-20 2007-04-04 Alcon Inc TREATMENT OF AMD WITH A COMBINATION OF INGREDIENTS
JP2007526019A (ja) * 2003-07-10 2007-09-13 アルコン，インコーポレイティド 眼科用薬物送達デバイス
DE10337863A1 (de) 2003-08-18 2005-03-17 Merck Patent Gmbh Verwendung von Chromen-4-on-Derivaten
US20060286173A1 (en) * 2003-08-20 2006-12-21 Kazuhito Yamada Drug delivery system for sub-tenon s capsule adminstration of fine grains
WO2005020907A2 (en) 2003-08-26 2005-03-10 Vista Scientific Ocular drug delivery device
CA2539324A1 (en) 2003-09-18 2005-03-31 Macusight, Inc. Transscleral delivery
US20090148527A1 (en) * 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
WO2005048873A2 (en) * 2003-11-12 2005-06-02 Alcon, Inc. Kit for administration of a drug
US20090043321A1 (en) * 2004-04-29 2009-02-12 Iscience Interventional Corporation Apparatus And Method For Surgical Enhancement Of Aqueous Humor Drainage
US20080058704A1 (en) * 2004-04-29 2008-03-06 Michael Hee Apparatus and Method for Ocular Treatment
US20060024350A1 (en) * 2004-06-24 2006-02-02 Varner Signe E Biodegradable ocular devices, methods and systems
US20060110428A1 (en) * 2004-07-02 2006-05-25 Eugene Dejuan Methods and devices for the treatment of ocular conditions
US20060047250A1 (en) * 2004-08-30 2006-03-02 Hickingbotham Dyson W Fluid delivery device
US7402156B2 (en) * 2004-09-01 2008-07-22 Alcon, Inc. Counter pressure device for ophthalmic drug delivery
US7226435B2 (en) * 2004-10-14 2007-06-05 Alcon, Inc. Drug delivery device
KR20070101865A (ko) * 2004-12-22 2007-10-17 알콘, 인코퍼레이티드 안과용 약물 전달 장치
US8663639B2 (en) 2005-02-09 2014-03-04 Santen Pharmaceutical Co., Ltd. Formulations for treating ocular diseases and conditions
GB2438544A (en) 2005-02-09 2007-11-28 Cooper Internat Corp Liquid formulations for treatment of diseases or conditions
JP2006257080A (ja) * 2005-02-18 2006-09-28 Santen Pharmaceut Co Ltd ステロイド化合物の副作用軽減または回避方法
CN101119733A (zh) * 2005-02-18 2008-02-06 参天制药株式会社 减轻或避免甾族化合物副作用的方法
US20100196509A1 (en) 2005-02-28 2010-08-05 Jonathan Braun Methods for Diagnosis and Treatment of Endometrial Cancer
WO2006110487A1 (en) * 2005-04-08 2006-10-19 Surmodics, Inc. Sustained release implants for subretinal delivery
US8318906B2 (en) 2005-04-15 2012-11-27 The Regents Of The University Of California EMP2 antibodies and their therapeutic uses
US20070038174A1 (en) * 2005-08-09 2007-02-15 Hopkins Mark A Ophthalmic injector system
US20070060887A1 (en) * 2005-08-22 2007-03-15 Marsh David A Ophthalmic injector
WO2007047626A1 (en) * 2005-10-14 2007-04-26 Alcon, Inc. Combination treatment with anecortave acetate and bevacizumab or ranibizumab for pathologic ocular angiogenesis
EP1944051A4 (en) * 2005-10-31 2009-09-02 Terumo Corp PUNCTION DEVICE, DOSING DEVICE AND PUNCTURE PROCESS
US20070156096A1 (en) * 2005-11-10 2007-07-05 Terumo Kabushiki Kaisha Puncture device
US7611492B2 (en) * 2005-11-10 2009-11-03 Terumo Kabushiki Kaisha Puncture device
CN101346473A (zh) * 2005-12-22 2009-01-14 爱尔康研究有限公司 用于在具有补体因子h的风险变体的患者中预防和治疗年龄相关性黄斑变性的c3-转化酶抑制剂
JP5528708B2 (ja) 2006-02-09 2014-06-25 参天製薬株式会社 安定な製剤ならびにそれらを調製および使用する方法
US20070202186A1 (en) 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
AU2007230964B2 (en) 2006-03-23 2012-07-19 Santen Pharmaceutical Co., Ltd. Formulations and methods for vascular permeability-related diseases or conditions
US20210393436A1 (en) * 2006-05-02 2021-12-23 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
US8197435B2 (en) * 2006-05-02 2012-06-12 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
US7862540B2 (en) * 2006-05-17 2011-01-04 Alcon Research, Ltd. Ophthalmic injection device using shape memory alloy
US7811252B2 (en) * 2006-05-17 2010-10-12 Alcon Research, Ltd. Dosage control device
US20070270768A1 (en) * 2006-05-17 2007-11-22 Bruno Dacquay Mechanical Linkage Mechanism For Ophthalmic Injection Device
US20070270750A1 (en) * 2006-05-17 2007-11-22 Alcon, Inc. Drug delivery device
US20070268340A1 (en) * 2006-05-17 2007-11-22 Bruno Dacquay Ophthalmic Injection System and Method Using Piezoelectric Array
US7674243B2 (en) * 2006-05-17 2010-03-09 Alcon Inc. Ophthalmic injection device using piezoelectric array
US7887521B2 (en) * 2006-05-17 2011-02-15 Alcon Research, Ltd. Ophthalmic injection system
US7815603B2 (en) * 2006-05-17 2010-10-19 Alcon Research, Ltd. Ophthalmic injection method
US20080125712A1 (en) * 2006-09-26 2008-05-29 Alcon Manufacturing, Ltd. Ophthalmic injection system
US20080097379A1 (en) * 2006-09-26 2008-04-24 Alcon Manufacturing, Ltd. Ophthalmic injection method
US20080097390A1 (en) * 2006-09-27 2008-04-24 Alcon Manufacturing, Ltd. Spring actuated delivery system
BRMU8602090Y8 (pt) * 2006-10-05 2021-06-22 Hexsel Doris disposição aplicada a cânula para preenchimentos cutâneos
US20080281292A1 (en) * 2006-10-16 2008-11-13 Hickingbotham Dyson W Retractable Injection Port
ES2355960T3 (es) * 2006-10-16 2011-04-01 Alcon Research, Ltd. Conjunto de reutilización limitada recargable univaersal para pieza de mano oftálmica.
AU2007348611A1 (en) * 2006-10-16 2008-09-12 Alcon Research, Ltd. Method of operating ophthalmic hand piece with disposable end
US9022970B2 (en) 2006-10-16 2015-05-05 Alcon Research, Ltd. Ophthalmic injection device including dosage control device
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
US20080265343A1 (en) * 2007-04-26 2008-10-30 International Business Machines Corporation Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
US20080269318A1 (en) * 2007-04-30 2008-10-30 Carmelo Romano Treatment of age-related macular degeneration using inhibitors of complement factor d
US20090018548A1 (en) * 2007-07-13 2009-01-15 Charles Steven T Pneumatically-Powered Intraocular Lens Injection Device with Removable Cartridge
US20090018512A1 (en) * 2007-07-13 2009-01-15 Charles Steven T Pneumatically-Powered Ophthalmic Injector
US7740619B2 (en) * 2007-08-01 2010-06-22 Alcon Research, Ltd. Spring driven ophthalmic injection device with safety actuator lockout feature
US7629768B2 (en) * 2007-08-03 2009-12-08 Alcon Research, Ltd. Easy cleaning C-shaped charging base
US20090036842A1 (en) * 2007-08-03 2009-02-05 Raffi Pinedjian Consumable Activation Lever For Injection Device
EP2214608B1 (en) 2007-11-08 2015-03-04 Alimera Sciences, Inc. Ocular implantation device
USD592746S1 (en) 2007-11-08 2009-05-19 Alimera Sciences Ocular implantation device
US8790366B2 (en) * 2007-11-13 2014-07-29 Alcon Research, Ltd. Fan-shaped cannula for sealing ophthalmic incisions
KR101634983B1 (ko) * 2008-01-07 2016-07-01 살루타리스 메디컬 디바이스즈, 인코퍼레이티드 눈의 후부에 대한 방사선의 전달을 위한 외안의 최소한의 수술 방법 및 장치
US9056201B1 (en) * 2008-01-07 2015-06-16 Salutaris Medical Devices, Inc. Methods and devices for minimally-invasive delivery of radiation to the eye
US10022558B1 (en) * 2008-01-07 2018-07-17 Salutaris Medical Devices, Inc. Methods and devices for minimally-invasive delivery of radiation to the eye
US9873001B2 (en) 2008-01-07 2018-01-23 Salutaris Medical Devices, Inc. Methods and devices for minimally-invasive delivery of radiation to the eye
US8608632B1 (en) * 2009-07-03 2013-12-17 Salutaris Medical Devices, Inc. Methods and devices for minimally-invasive extraocular delivery of radiation and/or pharmaceutics to the posterior portion of the eye
US8602959B1 (en) 2010-05-21 2013-12-10 Robert Park Methods and devices for delivery of radiation to the posterior portion of the eye
AU2015204094B2 (en) * 2008-01-07 2017-02-23 Salutaris Medical Devices, Inc Methods and devices for minimally-invasive extraocular delivery of radiation to the posterior portion of the eye
GB0802044D0 (en) * 2008-02-05 2008-03-12 Helica Instr Ltd Needle for opthalmic procedures
TWI607748B (zh) * 2008-04-24 2017-12-11 莎魯塔理斯醫療設備股份有限公司 用於最小侵入性眼外遞送輻射至眼睛後部之方法及裝置
US8945086B2 (en) * 2008-07-01 2015-02-03 Bruce Becker Retrobulbar needle and methods of use
US8821870B2 (en) 2008-07-18 2014-09-02 Allergan, Inc. Method for treating atrophic age related macular degeneration
CA2734185C (en) 2008-08-15 2017-02-28 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods for using interferon gamma to absorb fluid from the subretinal space
US20100098772A1 (en) * 2008-10-21 2010-04-22 Allergan, Inc. Drug delivery systems and methods for treating neovascularization
US8702677B2 (en) * 2008-10-31 2014-04-22 Warsaw Orthopedic, Inc. Device and method for directional delivery of a drug depot
US9095506B2 (en) 2008-11-17 2015-08-04 Allergan, Inc. Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
KR20110108334A (ko) 2008-12-04 2011-10-05 사노피 결정질 형태
TW201034675A (en) 2008-12-18 2010-10-01 Sanofi Aventis Method for treating macular degeneration
USD691268S1 (en) 2009-01-07 2013-10-08 Salutaris Medical Devices, Inc. Fixed-shape cannula for posterior delivery of radiation to eye
USD691270S1 (en) 2009-01-07 2013-10-08 Salutaris Medical Devices, Inc. Fixed-shape cannula for posterior delivery of radiation to an eye
USD642266S1 (en) 2010-08-24 2011-07-26 Marsteller Laurence J Brachytherapy device
USD691269S1 (en) 2009-01-07 2013-10-08 Salutaris Medical Devices, Inc. Fixed-shape cannula for posterior delivery of radiation to an eye
USD691267S1 (en) 2009-01-07 2013-10-08 Salutaris Medical Devices, Inc. Fixed-shape cannula for posterior delivery of radiation to eye
US20100191177A1 (en) * 2009-01-23 2010-07-29 Iscience Interventional Corporation Device for aspirating fluids
US8425473B2 (en) 2009-01-23 2013-04-23 Iscience Interventional Corporation Subretinal access device
USD615645S1 (en) 2009-02-06 2010-05-11 Luca Brigatti Fixed-shape cannula for posterior delivery of radiation to eye
USD616540S1 (en) 2009-02-06 2010-05-25 Luca Brigatti Fixed-shape cannula for posterior delivery of radiation to eye
USD616087S1 (en) 2009-02-06 2010-05-18 Luca Brigatti Fixed-shape cannula for posterior delivery of radiation to eye
USD616088S1 (en) 2009-02-06 2010-05-18 Luca Brigatti Fixed-shaped cannula for posterior delivery of radiation to eye
US8632511B2 (en) 2009-05-06 2014-01-21 Alcon Research, Ltd. Multiple thermal sensors in a multiple processor environment for temperature control in a drug delivery device
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US12478503B2 (en) 2009-05-18 2025-11-25 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
EP3785683B1 (en) 2009-05-18 2023-11-01 Dose Medical Corporation Drug eluting ocular implant
US8304524B2 (en) 2009-07-23 2012-11-06 Baxter International Inc. Manufacture of factor H (FH) and FH-derivatives from plasma
RU2405575C1 (ru) * 2009-08-17 2010-12-10 Владимир Константинович Гаврилов Медицинская игла
CA2781290A1 (en) 2009-11-20 2011-05-26 Lynn K. Gordon Epithelial membrane protein-2 (emp2) and proliferative vitreoretinopathy (pvr)
US8177747B2 (en) 2009-12-22 2012-05-15 Alcon Research, Ltd. Method and apparatus for drug delivery
MX2012006598A (es) 2009-12-23 2012-06-19 Alcon Res Ltd Canula trocar de valvula oftalmica.
US8343106B2 (en) 2009-12-23 2013-01-01 Alcon Research, Ltd. Ophthalmic valved trocar vent
US8529492B2 (en) 2009-12-23 2013-09-10 Trascend Medical, Inc. Drug delivery devices and methods
EP2536433B1 (en) 2010-02-19 2017-08-02 The Regents of The University of California Epithelial membrane protein 2 (emp2) binding reagents and their therapeutic uses in ocular diseases
WO2011150284A2 (en) 2010-05-26 2011-12-01 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
JP2012020042A (ja) * 2010-07-16 2012-02-02 Japan Imposing Co Ltd 皮下注射針
AU2011285548B2 (en) * 2010-08-05 2014-02-06 Forsight Vision4, Inc. Combined drug delivery methods and apparatus
EP2627292B1 (en) 2010-10-15 2018-10-10 Clearside Biomedical, Inc. Device for ocular access
EP2654715B1 (en) 2010-11-24 2017-01-25 Dose Medical Corporation Drug eluting ocular implant
US10245178B1 (en) 2011-06-07 2019-04-02 Glaukos Corporation Anterior chamber drug-eluting ocular implant
WO2013040238A2 (en) 2011-09-13 2013-03-21 Vista Scientific Llc Sustained release ocular drug delivery devices and methods of manufacture
KR20150095628A (ko) * 2012-10-08 2015-08-21 우니베르지태트 라이치히 공막의 의학적 치료용 장치
CA2890238A1 (en) 2012-11-02 2014-05-08 Merck Patent Gmbh Method of reducing adverse effects in a cancer patient undergoing treatment with a mek inhibitor
US10173075B2 (en) 2012-11-07 2019-01-08 Ip Liberty Vision Corporation Light-guided ophthalmic radiation device
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
AU2013202965B2 (en) 2013-03-15 2016-07-21 Takeda Pharmaceutical Company Limited Improved method for producing factor h from a plasma precipitation fraction
AU2013203048A1 (en) 2013-03-15 2014-10-02 Baxalta GmbH Isolation of factor h from fraction i paste
CN116327482A (zh) 2013-05-03 2023-06-27 科尼尔赛德生物医学公司 用于眼部注射的设备和方法
US10010447B2 (en) 2013-12-18 2018-07-03 Novartis Ag Systems and methods for subretinal delivery of therapeutic agents
US9730834B2 (en) 2013-12-20 2017-08-15 Novartis Ag Variable stiffness cannula and methods for a surgical system
US10166143B2 (en) 2013-12-31 2019-01-01 Ip Liberty Vision Corporation Versatile light-guided ophthalmic treatment system
US10117578B2 (en) 2013-12-31 2018-11-06 Ip Liberty Vision Corporation Luminescent ophthalmic device
ES3013632T3 (en) 2014-02-12 2025-04-14 Genentech Inc Apparatus for suprachoroidal administration of therapeutic agent
CN103919642A (zh) * 2014-03-14 2014-07-16 中国人民解放军第三军医大学第一附属医院 巩膜后注射系统
BR112016023453A2 (pt) * 2014-04-09 2021-06-01 Peter Iseli Hans dispositivo para um tratamento médico de uma esclera
JP6392162B2 (ja) * 2014-05-26 2018-09-19 株式会社スズキプレシオン 注入針装置及び注入器具セット
WO2015184173A1 (en) 2014-05-29 2015-12-03 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
USD760381S1 (en) 2014-06-25 2016-06-28 Donald Fox Orbital injection cannula
JPWO2016006342A1 (ja) * 2014-07-08 2017-04-27 テルモ株式会社 注射針
US9764122B2 (en) 2014-07-25 2017-09-19 Warsaw Orthopedic, Inc. Drug delivery device and methods having an occluding member
US9775978B2 (en) 2014-07-25 2017-10-03 Warsaw Orthopedic, Inc. Drug delivery device and methods having a retaining member
US10258502B2 (en) 2014-09-18 2019-04-16 Orbit Biomedical Limited Therapeutic agent delivery device
US9867952B2 (en) * 2014-10-07 2018-01-16 N&M Surgical Advancements, LLC Delivery tool of a viscoelastic syringe assembly
EP3081198A1 (en) * 2015-04-14 2016-10-19 Eyevensys Elektroporation device for the eye with a support and with a needle electrode
US11045665B2 (en) 2015-05-06 2021-06-29 Ip Liberty Vision Corporation Light-guided ophthalmic radiation device
WO2016187426A1 (en) 2015-05-19 2016-11-24 Amorphex Therapeutics Llc A device that delivers a sustained low-dose of a myopia-suppressing drug
US10507134B2 (en) * 2015-05-27 2019-12-17 Novartis Ag Systems and methods for pulsed posterior vitreous detachment creation
WO2017040853A1 (en) 2015-09-02 2017-03-09 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
US10182939B2 (en) 2015-09-16 2019-01-22 Novartis Ag Hydraulic injector and methods for intra-ocular lens insertion
US11564833B2 (en) 2015-09-25 2023-01-31 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
US10076650B2 (en) 2015-11-23 2018-09-18 Warsaw Orthopedic, Inc. Enhanced stylet for drug depot injector
US10478553B2 (en) 2016-03-09 2019-11-19 Orbit Biomedical Limited Apparatus for subretinal administration of therapeutic agent via a curved needle
WO2017184881A1 (en) 2016-04-20 2017-10-26 Harold Alexander Heitzmann Bioresorbable ocular drug delivery device
JP2019514581A (ja) 2016-05-02 2019-06-06 クリアサイド バイオメディカル，インコーポレイテッド 眼の薬物送達のためのシステムおよび方法
USD814637S1 (en) 2016-05-11 2018-04-03 Salutaris Medical Devices, Inc. Brachytherapy device
USD814638S1 (en) 2016-05-11 2018-04-03 Salutaris Medical Devices, Inc. Brachytherapy device
USD815285S1 (en) 2016-05-11 2018-04-10 Salutaris Medical Devices, Inc. Brachytherapy device
USD802756S1 (en) 2016-06-23 2017-11-14 Warsaw Orthopedic, Inc. Drug pellet cartridge
US10973681B2 (en) 2016-08-12 2021-04-13 Clearside Biomedical, Inc. Devices and methods for adjusting the insertion depth of a needle for medicament delivery
USD808528S1 (en) 2016-08-31 2018-01-23 Salutaris Medical Devices, Inc. Holder for a brachytherapy device
USD808529S1 (en) 2016-08-31 2018-01-23 Salutaris Medical Devices, Inc. Holder for a brachytherapy device
US10434261B2 (en) 2016-11-08 2019-10-08 Warsaw Orthopedic, Inc. Drug pellet delivery system and method
EP3551216B1 (en) 2016-12-07 2024-07-10 Mayo Foundation for Medical Education and Research Methods and materials for using fibrin supports for retinal pigment epithelium transplantation
CN114848286A (zh) 2016-12-19 2022-08-05 新世界医学有限公司 眼部治疗装置和相关使用方法
US11273072B2 (en) 2017-01-13 2022-03-15 Gyroscope Therapeutics Limited Suprachoroidal injection device
US11439772B2 (en) * 2017-03-17 2022-09-13 Jasperate, Inc. Hollow needle for access in non-linear path
DE102017209202A1 (de) * 2017-05-31 2018-12-06 Geuder Ag Vorrichtung zur Präparation eines menschlichen oder tierischen Gewebes für ein Einbringen eines Transplantats oder Implantats
US12285627B2 (en) 2018-10-19 2025-04-29 Colorado School Of Mines Fabrication and irradiation of a radioactive isotope skin patch
WO2020163850A1 (en) * 2019-02-08 2020-08-13 Mayo Foundation For Medical Education And Research Implantation device
US11850188B2 (en) 2019-04-01 2023-12-26 Amo Development, Llc Corneal lenticule extraction tool
US20210338481A1 (en) * 2020-04-20 2021-11-04 Bruce B. Becker Lacrimal gland implant for drug delivery and method
JP2024503739A (ja) 2021-01-25 2024-01-26 アルコン インコーポレイティド 網膜下注入のための方法及び装置
CN113041019B (zh) * 2021-03-11 2022-11-22 沈健 一种房角分离器
WO2024073759A1 (en) * 2022-09-30 2024-04-04 FUJIFILM Cellular Dynamics, Inc. Apparatus and methods for delivery of cell compositions
WO2024091586A1 (en) * 2022-10-28 2024-05-02 Salutaris Medical Devices, Inc. Radionuclide brachytherapy source systems for ocular radiotherapy
WO2024261624A1 (en) * 2023-06-22 2024-12-26 Alcon Inc. Methods and apparatus for subretinal delivery

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3416530A (en) 1966-03-02 1968-12-17 Richard A. Ness Eyeball medication dispensing tablet
US3439675A (en) 1966-06-14 1969-04-22 Becton Dickinson Co Deformable needle assembly
US3828777A (en) 1971-11-08 1974-08-13 Alza Corp Microporous ocular device
US4014335A (en) 1975-04-21 1977-03-29 Alza Corporation Ocular drug delivery device
US4300557A (en) 1980-01-07 1981-11-17 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for treating intraocular malignancies
US4327725A (en) 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4759756A (en) 1984-09-14 1988-07-26 Baxter Travenol Laboratories, Inc. Reconstitution device
EP0228185B1 (en) * 1985-11-27 1990-07-25 Thomas C. White Tissue-implantable fluid-dissipating device
US5322691A (en) 1986-10-02 1994-06-21 Sohrab Darougar Ocular insert with anchoring protrusions
US5147647A (en) 1986-10-02 1992-09-15 Sohrab Darougar Ocular insert for the fornix
US4759746A (en) * 1987-05-14 1988-07-26 Straus Jeffrey G Retro-bulbar needle
US4853224A (en) 1987-12-22 1989-08-01 Visionex Biodegradable ocular implants
US4997652A (en) 1987-12-22 1991-03-05 Visionex Biodegradable ocular implants
DE3905050A1 (de) 1989-02-18 1990-08-30 Lohmann Therapie Syst Lts Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (ii)
US4946450A (en) 1989-04-18 1990-08-07 Biosource Genetics Corporation Glucan/collagen therapeutic eye shields
US5817075A (en) * 1989-08-14 1998-10-06 Photogenesis, Inc. Method for preparation and transplantation of planar implants and surgical instrument therefor
US5164188A (en) 1989-11-22 1992-11-17 Visionex, Inc. Biodegradable ocular implants
US5290892A (en) 1990-11-07 1994-03-01 Nestle S.A. Flexible intraocular lenses made from high refractive index polymers
US5378475A (en) 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US5167618A (en) * 1991-02-22 1992-12-01 Kershner Robert M Capsulotomy forceps
US5127831A (en) 1991-06-03 1992-07-07 Bab Itai Flexible-end irrigation probe
US5679666A (en) 1991-11-22 1997-10-21 Alcon Laboratories, Inc. Prevention and treatment of ocular neovascularization by treatment with angiostatic steroids
US5770592A (en) 1991-11-22 1998-06-23 Alcon Laboratories, Inc. Prevention and treatment of ocular neovascularization using angiostatic steroids
WO1993020784A1 (en) 1992-04-10 1993-10-28 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University A microneedle for injection of ocular blood vessels
US5178635A (en) 1992-05-04 1993-01-12 Allergan, Inc. Method for determining amount of medication in an implantable device
FR2690846B1 (fr) 1992-05-05 1995-07-07 Aiache Jean Marc Forme galenique pour administration oculaire et procede de preparation.
WO1994005257A1 (en) 1992-09-08 1994-03-17 Allergan, Inc. Sustained release of ophthalmic drugs from a soluble polymer drug delivery vehicle
WO1995003009A1 (en) 1993-07-22 1995-02-02 Oculex Pharmaceuticals, Inc. Method of treatment of macular degeneration
US5443505A (en) 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
US5516522A (en) 1994-03-14 1996-05-14 Board Of Supervisors Of Louisiana State University Biodegradable porous device for long-term drug delivery with constant rate release and method of making the same
WO1995026734A1 (en) 1994-04-04 1995-10-12 Freeman William R Use of phosphonylmethoxyalkyl nucleosides for the treatment of raised intraocular pressure
US5466233A (en) 1994-04-25 1995-11-14 Escalon Ophthalmics, Inc. Tack for intraocular drug delivery and method for inserting and removing same
AUPM897594A0 (en) 1994-10-25 1994-11-17 Daratech Pty Ltd Controlled release container
EP0788351B1 (en) 1994-11-10 2003-02-05 The University of Kentucky Research Foundation Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body
US5725493A (en) 1994-12-12 1998-03-10 Avery; Robert Logan Intravitreal medicine delivery
WO1996036377A1 (en) 1995-05-14 1996-11-21 Optonol Ltd. Intraocular implant, delivery device, and method of implantation
US5773019A (en) 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
US5743274A (en) 1996-03-18 1998-04-28 Peyman; Gholam A. Macular bandage for use in the treatment of subretinal neovascular members
US5824073A (en) * 1996-03-18 1998-10-20 Peyman; Gholam A. Macular indentor for use in the treatment of subretinal neovascular membranes
US5904144A (en) 1996-03-22 1999-05-18 Cytotherapeutics, Inc. Method for treating ophthalmic diseases
JP3309175B2 (ja) 1996-03-25 2002-07-29 参天製薬株式会社 タンパク性薬物含有強膜プラグ
US5797898A (en) 1996-07-02 1998-08-25 Massachusetts Institute Of Technology Microchip drug delivery devices
US5665069A (en) 1996-07-19 1997-09-09 Cumer; Patricia Lynn Pressure-directed peribulbar anesthesia delivery device
EP1003569B1 (en) 1997-08-11 2004-10-20 Allergan, Inc. Sterile bioerodible implant device containing retinoid with improved biocompatability and method of manufacture
US5902598A (en) 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
CA2321560C (en) 1998-03-13 2007-05-22 Johns Hopkins University School Of Medicine The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation
US6028099A (en) 1998-03-13 2000-02-22 John Hopkins University, School Of Medicine Use of an inhibitor of the protein tyrosine kinase pathway in the treatment of choroidal neovascularization
US6309374B1 (en) 1998-08-03 2001-10-30 Insite Vision Incorporated Injection apparatus and method of using same
US6378526B1 (en) 1998-08-03 2002-04-30 Insite Vision, Incorporated Methods of ophthalmic administration
US6135984A (en) 1999-01-06 2000-10-24 Dishler; Jon G. Cannula for use in corrective laser eye surgery

Also Published As

Publication number Publication date
HK1049438B (en) 2005-08-26
AR039133A2 (es) 2005-02-09
EP1522289A2 (en) 2005-04-13
JP2003511204A (ja) 2003-03-25
AU775149B2 (en) 2004-07-22
MXPA02002376A (es) 2002-08-28
BR0014930A (pt) 2003-07-15
PT1221918E (pt) 2005-06-30
EP1221918A1 (en) 2002-07-17
AU7854800A (en) 2001-04-30
CA2383572A1 (en) 2001-04-26
EP1522289A3 (en) 2008-01-23
DE60018777D1 (de) 2005-04-21
BR0014930B1 (pt) 2009-01-13
HK1049438A1 (en) 2003-05-16
WO2001028473A1 (en) 2001-04-26
DE60018777T2 (de) 2006-02-02
AR036065A2 (es) 2004-08-11
CA2383572C (en) 2007-12-11
ES2240180T3 (es) 2005-10-16
ATE290837T1 (de) 2005-04-15
TW467740B (en) 2001-12-11
AR026075A1 (es) 2002-12-26
US6413245B1 (en) 2002-07-02
EP1221918B1 (en) 2005-03-16

Similar Documents

Publication Publication Date Title
AR036066A2 (es) Metodo para suministrar una droga a un ojo humano
AR039132A2 (es) Metodo para administrar un agente farmaceuticamente activo al ojo teniendo dicho ojo una esclerotica, una capsula de tenon y una macula
US9005284B2 (en) Method and apparatus for treating dilating the ethmoid infundibulum
PT1301238E (pt) Agulhas revestidas com vacina
FR12C0067I1 (fr) Implant oculaire biodegradable
BR0014928A (pt) Dispositivo e processo para distribuição de medicamento para um olho humano
ES2166829T3 (es) Composicion acuosa espumante.
WO2006014484A3 (en) Methods and devices for the treatment of ocular conditions
BR0010869A (pt) Método para administrar um corticosteróide a um segmento posterior de um olho e dispositivo de liberação sustentada implantável
DE60044464D1 (de) Bukkale transmukosale arzneidarreichung unter verwendung einer festen lösung
AR046307A1 (es) Metodo de pretratamiento y sistema para mejorar la administracion transdermica de drogas
ATE195065T1 (de) Biologisch abbaubarer sklerastopfen
AR042917A1 (es) Dispositivo de liberacion sostenida para la administracion ocular de agentes adrenergicos y uso de agentes adrenergicos para su preparacion
NZ506408A (en) Pharmaceutical compositions
WO2003008005A3 (en) Catheter and implants for the delivery of therapeutic agents to tissues
EP1325753A3 (en) Bio-compatible means for controlled drug delivery to tissue and method of use
PT1246662E (pt) Sistema de administracao de um agente benefico ormotico
WO2005063204A3 (en) Drug delivery device with suture ring
CO5210863A1 (es) Medicamento para el tratamiento de urgencia urinaria incre- mentada o incontinencia urinaria . . . . .
SE9901257D0 (sv) Behandling av smärta efter ledoperation
RU2000111751A (ru) Способ лечения кисты молочной железы
WO2002064108A3 (en) Delivery of biologically active agents
ATE204169T1 (de) Polyamin-antagonisten enthaltende intraokulare irrigationslösung
ECSP003689A (es) Uso de (+)- tramadol, o- demetiltramadol y/o (+)- o- demetiltramadol, o-desmetil-n-monodesmetil-tramadol, particularmente (+) -o- desmetil-n-monodesmetil-tramadol para la preparacion de un medicamento para el tratamiento de urgencia urinaria incremen
AR024199A1 (es) Uso de la buprenorfina en la preparacion de un disposotivo de suministro transdermico

Legal Events

Date Code Title Description
FB Suspension of granting procedure